Efficacy and Safety of Programmed Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Checkpoint Inhibitors in Patients With Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysis.
Clin Oncol (R Coll Radiol)
; 36(1): e20-e30, 2024 01.
Article
in En
| MEDLINE
| ID: mdl-37993317
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Programmed Cell Death 1 Receptor
/
Prostatic Neoplasms, Castration-Resistant
Type of study:
Systematic_reviews
Limits:
Humans
/
Male
Language:
En
Journal:
Clin Oncol (R Coll Radiol)
Journal subject:
NEOPLASIAS
Year:
2024
Document type:
Article
Country of publication: